neuroCare provides sustainable treatments of depression, ADHD and rehabilitation using neuromodulation technologies combined with psychotherapy. With the leading technology brand neuroConn, the company not only achieves good therapeutic results in their own neuroCare clinics, but have been associated for over 10 years with practice-oriented medical technology for neuroscience research and the treatment of neuropsychological disorders. In close cooperation with leading research institutions and clinics worldwide, neuroConn technology for neurofeedback, full-band DC-EEG and tDCS is designed following the latest medical research standards. In the neuroCademy they train therapists/researchers in techniques of neuromodulation and integrated therapy concepts for their daily work with patients.